332 related articles for article (PubMed ID: 18521898)
1. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
[TBL] [Abstract][Full Text] [Related]
3. Fucosyltransferase and alpha-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue.
Wang JW; Ambros RA; Weber PB; Rosano TG
Cancer Res; 1995 Aug; 55(16):3654-8. PubMed ID: 7627975
[TBL] [Abstract][Full Text] [Related]
4. Serum glutathione-S-transferase and glutathione reductase activity in head and neck cancer patients.
Patel BP; Raval GN; Rawal RM; Patel JB; Sainger RN; Patel MM; Shah MH; Patel DD; Patel PS
Neoplasma; 2002; 49(4):260-6. PubMed ID: 12382026
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein electrophoretic pattern in sera of patients with oral precancerous conditions and upper aerodigestive tract cancer.
Patel PS; Rawal RM; Raval GN; Patel BP; Patel YV; Shah SG; Balar DB; Patel DD
J Exp Clin Cancer Res; 1997 Mar; 16(1):65-70. PubMed ID: 9148863
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
Rajpura KB; Patel PS; Chawda JG; Shah RM
J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
9. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
10. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD
Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576
[TBL] [Abstract][Full Text] [Related]
11. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
Shashikanth MC; Rao BB
Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
[TBL] [Abstract][Full Text] [Related]
12. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
Ghosh M; Nayak BR
Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
[TBL] [Abstract][Full Text] [Related]
13. Selenium therapy in patients with precancerous and malignant oral cavity lesions: preliminary results.
Toma S; Micheletti A; Giacchero A; Coialbu T; Collecchi P; Esposito M; Rotondi M; Albanese E; Cantoni E
Cancer Detect Prev; 1991; 15(6):491-4. PubMed ID: 1782639
[TBL] [Abstract][Full Text] [Related]
14. [The value of serum alpha-L-fucosidase activity in the diagnosis of primary liver cancer].
Wei X; Wang S; Rui J
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):148-50. PubMed ID: 11776645
[TBL] [Abstract][Full Text] [Related]
15. Effect of L-fucose and D-glucose concentration on L-fucoprotein metabolism in human Hep G2 cells and changes in fucosyltransferase and alpha-L-fucosidase activity in liver of diabetic rats.
Wiese TJ; Dunlap JA; Yorek MA
Biochim Biophys Acta; 1997 Apr; 1335(1-2):61-72. PubMed ID: 9133643
[TBL] [Abstract][Full Text] [Related]
16. Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients.
Barlow JJ; DiCioccio RA; Dillard PH; Blumenson LE; Matta KL
J Natl Cancer Inst; 1981 Nov; 67(5):1005-9. PubMed ID: 6946242
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.
Porrini R; Vercellino V; Rocchetti V; Renò F; Giorda E; Pomato E; Cannas M; Sabbatini M
Minerva Stomatol; 2010 May; 59(5):233-9, 239-43. PubMed ID: 20502428
[TBL] [Abstract][Full Text] [Related]
18. Alpha-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence.
Fernández-Rodríguez J; Ayude D; de la Cadena MP; Martínez-Zorzano VS; de Carlos A; Caride-Castro A; de Castro G; Rodríguez-Berrocal FJ
Cancer Detect Prev; 2000; 24(2):143-9. PubMed ID: 10917134
[TBL] [Abstract][Full Text] [Related]
19. alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis.
Hashimoto S; Asao T; Takahashi J; Yagihashi Y; Nishimura T; Saniabadi AR; Poland DC; van Dijk W; Kuwano H; Kochibe N; Yazawa S
Cancer; 2004 Dec; 101(12):2825-36. PubMed ID: 15536618
[TBL] [Abstract][Full Text] [Related]
20. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
Sawhney H; Kumar CA
Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
